Moderate hypofractionation for prostate cancer: A user's guide

- Pryor, David I., Turner, Sandra L., Tai, Keen Hun, Tang, Colin, Sasso, Giuseppe, Dreosti, Marcus, Woo, Henry H., Wilton, Lee, Martin, Jarad M.

Randomized trial of a hypofractionated radiation regimen for the treatment of localized prostate cancer

- Catton, Charles N., Lukka, Himu, Tai, Keen Hun, Wu, Jackson S., Parliament, Matthew B., Tsakiridis, Theodoros, Corbett, Tom B., Tang, Colin, Dayes, Ian S., Warde, Padraig, Craig, Tim K., Julian, Jim A., Gu, Chu-Shu, Levine, Mark N., Martin, Jarad M., Supiot, Stéphane, Chung, Peter W. M., Bauman, Glenn S., Bahary, Jean-Paul, Ahmed, Shahida, Cheung, Patrick

Nurse-led group consultation intervention reduces depressive symptoms in men with localised prostate cancer: a cluster randomised controlled trial

- Schofield, Penelope, Gough, Karla, Duchesne, Gillian, Sanson-Fisher, Rob, Aranda, Sanchia, Lotfi-Jam, Kerryann, Bergin, Rebecca, Ugalde, Anna, Dudgeon, Paul, Crellin, Wallace, Schubach, Kathryn, Foroudi, Farshard, Tai, Keen Hun

Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial

- Duchesne, Gillian M., Woo, Henry H., Millar, Jeremy, Milne, Roger, Smith, Rosemary G., Spry, Nigel, Stockler, Martin, Syme, Rodney A., Tai, Keen Hun, Turner, Sandra, Bassett, Julie K., Bowe, Steven J., D'Este, Catherine, Frydenberg, Mark, King, Madeleine, Ledwich, Leo, Loblaw, Andrew, Malone, Shawn